Search for: "APOTEX CORPORATION" Results 121 - 135 of 135
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Sep 2008, 2:33 pm
: (IPRoo), Review of National Innovation System – Key points for corporate counsel: (Mallesons Stephen Jaques), Review of National Innovation System recommends creative commons: (creativecommons.org), Review of Innovation System released: (IP Menu News), What [right]’s in a [business] name: Westpac Banking Corporation v McMillan & Melbas On The Park Pty Ltd (formerly Credit Systems Australia Pty Ltd): (Australian Trade Marks Law Blog), Senator Kim Carr… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
14 Mar 2008, 6:07 am
While we put the Rezulin decision in the same line of authority, it lacks a clear holding that expert testimony about the meaning or violation of FDA regulations is inadmissible as a legal conclusion.An aside: Rezulin and some of the other cases also dealt with (and correctly excluded) supposed expert testimony about corporate intent. [read post]
14 Jan 2011, 10:07 am by Christa Culver
Certiorari stage documents:Opinion below (Court of Appeals for the Federal Circuit)Petition for certiorariBrief in oppositionAmicus brief of the Federal Timber Purchasers Committee, et al.Petitioner's reply Title: Pella Corporation v. [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
26 Feb 2011, 3:47 pm
Loser Microsoft (v. i4i) has that going for invalidity all the way to the Supreme Court, which always toadies to power, governmental or corporate. [read post]
1 Feb 2022, 4:08 pm by Ben Vernia
In addition, the department intervened and filed complaints in separate lawsuits against Independent Health Corporation and members of the Kaiser Permanente consortium alleging that those Medicare Advantage organizations submitted or caused the submission of inaccurate information about the health status of beneficiaries enrolled in their plans to increase reimbursement from Medicare.Unlawful KickbacksKickbacks in the healthcare industry are pernicious because of… [read post]
22 Feb 2008, 6:00 pm
: (Patent Baristas),Vietnam : new developments in patent protection for medical uses: (Patent Docs),Wisconsin Alumni Research Foundation licenses stem cell patents to BioTime: (IPBiz)Pharma & Biotech - ProductsFloxin (Ofloxacin) –US Supreme Court declines Daiichi Sankyo’s request for appeal of CAFC decision reversing Daichii’s initial win in its ofloxacin patent infringement case against Apotex: (IP Law360),Galvus (Vildagliptin) – Indian… [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
22 Jan 2009, 2:06 am
As we reported yesterday, the California Supreme Court denied the petitions for review in Wyeth v. [read post]
30 May 2008, 9:09 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 5-7 June: European research and innovation exhibition – Paris: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with… [read post]
24 Jun 2011, 3:25 pm by Christa Culver
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' supplemental briefRespondents' supplemental briefPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical AssociationCVSG Information:Invited: March 28, 2011Filed: May 26, 2011 (Grant) Title: Coleman v. [read post]
3 Feb 2011, 2:11 pm by Bexis
A few weeks ago a regular reader, and occasional correspondent, Prof. [read post]
29 Feb 2008, 8:00 am
: (creativecommons.org)Pharma & BiotechPharma & Biotech - GeneralScience Commons news: A commons-sense approach to winning the drug discovery lottery: (creativecommons.org),India: Hindu Business Line reports on why pharma companies are pushing for tax incentives: (Spicy IP), India: J Mitra gets injunction against Span Diagnostics in patent dispute before Delhi High Court over device used in detection of Hep C: (Generic Pharmaceuticals & IP), India: Patent Office releases… [read post]
6 Jul 2007, 4:29 am
We've already deplored the recent decision of the West Virginia Supreme Court rejecting the learned intermediary rule outright, State ex rel. [read post]